Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study

To see complete record on, please visit this link

Id: NCT04959253

Organisation Name: King's College London

Overal Status: Recruiting

Start Date: September 1, 2020

Last Update: July 22, 2021

Lead Sponsor: King's College London

Brief Summary: A single centre clinical trial to evaluate the feasibility, safety and efficacy of psilocybin, given under supportive conditions, in a randomised, blinded design in adult participants with treatment resistant major depressive disorder. The primary objective is to evaluate feasibility by measuring recruitment rates, dropout rates and by estimating the variance of the primary outcome measure (MADRS).

  • Treatment Resistant Depression

Total execution time in seconds: 0.27249217033386